Senior insider sale
SVP, Finance and Treasurer at ORUKA THERAPEUTICS, INC. — senior position signals high conviction
$1.39M
22.60K shares
What this filing means
AGARWAL ARJUN plans to sell 22.60K shares of ORUKA THERAPEUTICS, INC. valued at approximately $1.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001950047-26-004706
Officer· SVP, Finance and Treasurer
Since Aug 2024
22.60K
Shares to sell
$1.39M
Approx. market value
22.21K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
5/18/2026
19.75KRestricted Stock Units
N/A
3/14/2026
699.00Employee Stock Purchase Plan
Cash
12/8/2025
1.76KTotal acquired22.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/18/2026 | Exercise of Stock Options Cash | 19.75K | — |
3/14/2026 | Restricted Stock Units N/A | 699.00 | — |
12/8/2025 | Employee Stock Purchase Plan Cash | 1.76K | — |
| Total | 22.21K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
395.00
Market value
$16.3K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.21K
Market value
$1.38M
5/18/2026
Total
Units
22.60K
Value
$1.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/16/2026 | 395.00 | $16.3K | — | Completed |
| Planned — Approximate Date | ||||
5/18/2026 | 22.21K | $1.38M | NASDAQ | Planned |
| Total | 22.60K | $1.39M | ||